InsiderTrades

Form 4 for SRRK Scholar Rock Holding Corp

Accepted 2024-11-26 00:00:00 ET · period of report 2024-11-22 · accession 0001104659-24-123157 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-11-26 2024-11-22+ SRRK Marantz Jing L. Chief MEDICAL Off S - Sale+OE $37.06 -8,520 72.9K -10% -$315.8K
DM 2024-11-26 2024-11-22+ SRRK Marantz Jing L. Chief MEDICAL Off M - OptEx $8.59 +8,520 75.0K +13% +$73.2K
DM 2024-11-26 2024-11-22+ SRRK Marantz Jing L. Chief MEDICAL Off M - OptEx $0.00 -8,520 130.0K -6% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-11-25 S D 200 $40.72 72,855 D — — (F6) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.65 to $40.79, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
2 Common Common Stock 2024-11-25 S D 3,075 $39.93 73,055 D — — (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.65 to $40.49, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
3 Common Common Stock 2024-11-25 S D 2,100 $39.25 76,130 D — — (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.64 to $39.63, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
4 Common Common Stock 2024-11-25 S D 1,000 $38.04 78,230 D — — (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.63 to $38.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
5 Common Common Stock 2024-11-25 M A 6,375 $8.59 79,230 D — —
6 Common Common Stock 2024-11-22 M A 2,145 $8.59 75,000 D — —
7 Common Common Stock 2024-11-22 S D 2,145 $30.01 72,855 D — — (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.08, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
8 Derivative Stock Option (Right to Buy) 2024-11-22 M D 2,145 $0.00 136,375 D $8.59 · — to 2032-11-14 2,145 Common Stock (F7) The shares underlying this option vest over four years with the first installment vested on November 9, 2023 and the remainder vesting in twelve quarterly installments thereafter, provided the reporting person continues to have a service relationship with the Issuer as of the applicable vesting date.
9 Derivative Stock Option (Right to Buy) 2024-11-25 M D 6,375 $0.00 130,000 D $8.59 · — to 2032-11-14 6,375 Common Stock (F7) The shares underlying this option vest over four years with the first installment vested on November 9, 2023 and the remainder vesting in twelve quarterly installments thereafter, provided the reporting person continues to have a service relationship with the Issuer as of the applicable vesting date.